Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.355
+0.025 (1.88%)
Jul 8, 2025, 2:29 PM - Market open
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 134 employees as of December 31, 2024. The number of employees increased by 12 or 9.84% compared to the previous year.
Employees
134
Change (1Y)
12
Growth (1Y)
9.84%
Revenue / Employee
$2,113
Profits / Employee
-$719,992
Market Cap
69.05M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
INO News
- 22 hours ago - INOVIO to Present at Upcoming Scientific Conference - PRNewsWire
- 5 days ago - INOVIO Announces Pricing of $25 Million Public Offering - PRNewsWire
- 5 days ago - INOVIO Announces Proposed Public Offering - PRNewsWire
- 7 days ago - Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development - GlobeNewsWire
- 7 weeks ago - Inovio Pharmaceuticals, Inc. (INO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 2 months ago - Inovio Pharmaceuticals, Inc. (INO) Citizens JMP Life Sciences Conference (Transcript) - Seeking Alpha
- 2 months ago - INOVIO to Present at Upcoming Scientific and Investor Conferences - PRNewsWire